Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
Products
Antibodies
ELISA and Assay Kits
Research Areas
Infectious Disease
Resources
Purchasing
Reference Material
Contact Us
Location
Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
Telephone Numbers
Customer Service: (800) 227-6666 / (650) 697-3600
Contact Us
Additional Contact Details
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
| Catalog Number | Size | Price |
|---|---|---|
| LS-G145919-1 | 1 mg | $489 |
1 of 2
2 of 2
Coronavirus SARS-CoV-2 ORF8 Protein (Recombinant His) (aa16-121) - LS-G145919
Coronavirus SARS-CoV-2 ORF8 Protein (Recombinant His) (aa16-121) - LS-G145919
Description:
Coronavirus SARS-CoV-2 ORF8 Protein LS-G145919 is a Recombinant Coronavirus SARS-CoV-2 ORF8 Protein produced in E. coli aa 16-121 with His tag(s). For Research Use Only
Toll Free North America
(800) 227-6666
(800) 227-6666For Research Use Only
Overview
Description:
Coronavirus SARS-CoV-2 ORF8 Protein LS-G145919 is a Recombinant Coronavirus SARS-CoV-2 ORF8 Protein produced in E. coli aa 16-121 with His tag(s). For Research Use Only
Specifications
Type
Recombinant Protein
Target
Coronavirus SARS-CoV-2 ORF8 Protein
Species
Coronavirus SARS-CoV-2
Modifications
Unmodified
Conjugations
Unconjugated
Applications
- ELISA
- Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
- Western blot
Tag
His
Region
aa 16-121
Predicted Molecular Weight
13.4 kDa
Expression System
E. coli
Source Species
E. coli
Purification
Greater than 95% by SDS-PAGE
Bio-Activity
Not Tested
Endotoxin
Not Tested
Presentation
PBS, pH 7.2
Storage
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
LSBio Ratings
Coronavirus SARS-CoV-2 ORF8 Protein (Recombinant His) (aa16-121) - LS-G145919 has an LSBio Rating of
Publications (4)
Learn more about The LSBio Ratings Algorithm
Publications (1)
Differential Severe Acute Respiratory Syndrome Coronavirus 2-Specific Humoral Response in Inactivated Virus-Vaccinated, Convalescent, and Breakthrough-Infected Subjects. Luisa F Duarte, Yaneisi Vázquez, Benjamín Diethelm-Varela, Valentina Pavez, Roslye Berríos-Rojas, Constanza Méndez, Claudia A Riedel, Jessica A White, Alexis M Kalergis, Susan M Bueno, Pablo A González. The Journal of infectious diseases. 2023 October;228:857-867.
Customer Reviews (0)
Images
Western blot
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Western blot
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Western blot
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Western blot
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/23/2024
Date Requested: 11/23/2024
